'We have to up our game.' Regeneron co-founder details breakthrough to help COVID patients battle most severe strains
Dr. George Yancopoulos says he hopes the new discovery will be a game-changer for the roughly 10 million Americans whose immune systems won't respond to the current vaccines on the market.
Share:
